* Oscar Health Inc OSCR.N reported a quarterly adjusted
loss of
$1.05 per share for the quarter ended in December. The mean
expectation of seven analysts for the quarter was for a loss of
$1.16 per share.
* Revenue rose 100.6% to $995.13 million from a year ago;
analysts
expected $1.08 billion.
* Oscar Health Inc's reported EPS for the quarter was a loss
of
$1.05.
* The mean earnings estimate of analysts had fallen by
about 14.9%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Oscar Health Inc shares had risen by 66.3% this quarter.
* The company reported a quarterly loss of $226.05 million.
* Wall Street's median 12-month price target for Oscar
Health Inc
is $4.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from Refinitiv data February
10 at 02:00 a.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -1.16 -1.05 Beat
Sep. 30 2022 -0.73 -0.91 Missed
Jun. 30 2022 -0.48 -0.53 Missed
Mar. 31 2022 -0.21 -0.36 Missed